Phospholipase Activities in Clinical and Environmental Isolates of Acanthamoeba

Korean Journal of Parasitology

Volumn 49, Issue 1, 2011, Pages 1-8

  Matin, Abdul ^a   Jung, Suk Yul ^b  

^a INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

^b Namseoul University   (South Korea)

Author keywords

Acanthamoeba; Adhesion; Cytotoxicity; Human brain microvascular endothelial cell; Phospholipase A2; Phospholipase D

Indexed keywords

CITICOLINE; COMPOUND 48-80; CYTIDINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPASE D;

ACANTHAMOEBA; ACANTHAMOEBA ASTRONYXIS; ACANTHAMOEBA CASTELLANII; ACANTHAMOEBA ENCEPHALITIS; ACANTHAMOEBA KERATITIS; ARTICLE; BLOOD BRAIN BARRIER; CELL ADHESION; CONTROLLED STUDY; CYTOTOXICITY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PARASITE ISOLATION; PATHOGENESIS; PH; SPECTROPHOTOMETRY;

ACANTHAMOEBA; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; KERATITIS; PHOSPHOLIPASE D; PHOSPHOLIPASES A2; PROTOZOAN PROTEINS; SOIL;

ACANTHAMOEBA;

EID: 79953271054     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2011.49.1.1     Document Type: Article

References (28)

1. Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev 2006; 30: 564-595.
2. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003; 16: 273-307.
3. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34: 1001-1027.
4. Jung SY, Alsam S, Kim KS, Khan NA. Pathogen-pathogen interactions: a comparative study of Escherichia coli interactions with the clinical and environmental isolates of Acanthamoeba. World J Microbiol Biotechnol 2008; 24: 2339-2348.
5. Victoria EJ, Korn ED. Plasma membrane and soluble lysophospholipases of Acanthamoeba castellanii. Arch Biochem Biophys 1975; 171: 255-258.
6. Victoria EJ, Korn ED. Enzymes of phospholipid metabolism in the plasma membrane of Acanthamoeba castellanii. J Lipid Res 1975; 16: 54-60.
7. Cursons RTM, Brown TJ, Keys EA. Virulence of pathogenic free- living amoebae. J Parasitol 1978; 64: 744-745.
8. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122-143.
9. Exton JH. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol 2002; 144: 1-94.
10. McDermott M, Wakelam MJO, Morris AJ. Phospholipase D. Bio- chem Cell Biol 2004; 82: 225-253.
11. 2. Biol Pharm Bull 2004; 27: 1174-1178.
12. 2 enzymes. Foreword. Biol Pharm Bull 2004; 27: 1157.
13. Sissons J, Kim KS, Stins M, Jayasekera S, Alsam S, Khan NA. Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Infect Immun 2005; 73: 2704-2708.
14. Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuro immunol 1997; 76: 81-90.
15. Alsam S, Kim KS, Stins M, Rivas AO, Sissons J, Khan NA. Acanthamoeba interactions with human brain microvascular endothelial cells. Microb Pathog 2003; 35: 235-241.
16. Matin A, Stins M, Kim KS, Khan NA. Balamuthia mandrillaris exhibits metalloprotease activities. FEMS Immunol Med Microbiol 2006; 47: 83-91.
17. Sissons J, Alsam S, Jayasekera S, Khan NA. Ecto-ATPases of clinical and non-clinical isolates of Acanthamoeba. Microb Pathog 2004; 37: 231-239.
18. Leher H, Silvany R, Alizadeh H, Huang J, Niederkorn JY. Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun 1998; 66: 5-10.
19. Dennis EA, Rhee SG, Billah MM, Hannun YA. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J 1991; 5: 2068-2077.
20. Serhan CN, Haeggström JZ, Leslie CC. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 1996; 10: 1147-1158.
21. Oishi K, Raynor RL, Charp PA, Kuo JF. Regulation of protein ki- nase C by lysophospholipids. Potential role in signal transduction. J Biol Chem 1988; 263: 6865-6871.
22. Bryant AE, Stevens DL. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 1996; 64: 358-362.
23. Bunting M, Lorant DE, Bryant AE, Zimmerman GA, McIntyre TM, Stevens DL, Prescott SM. Alpha toxin from Clostridium per fringens induces proinflammatory changes in endothelial cells. J Clin Invest 1997; 100: 565-574.
24. Saffer LD, Long Krug SA, Schwartzman JD. The role of phospholipase in host cell penetration by Toxoplasma gondii. Am J Trop Med Hyg 1989; 40: 145-149.
25. Long-Krug SA, Fischer KJ, Hysmith RM, Ravdin JI. Phospholipase A enzymes of Entamoeba histolytica: description and subcellular localization. J Infect Dis 1985; 152: 536-541.
26. McNamara PJ, Bradley GA, Songer JG. Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Cory nebacterium pseudotuberculosis. Mol Microbiol 1994; 12: 921-930.
27. Kameyama S, Sato H, Murata R. The role of alpha-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs. Jpn J Med Sci Biol 1972; 25: 200.
28. Hänel H, Kirsch R, Schmidts HL, Kottmann H. New systematically active antimycotics from the beta-blocker category. Mycoses 1995; 38: 251-264.